Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 2
1967 5
1968 3
1969 3
1970 17
1971 9
1972 5
1973 2
1974 12
1975 18
1976 13
1977 21
1978 43
1979 38
1980 47
1981 47
1982 67
1983 72
1984 67
1985 76
1986 98
1987 107
1988 77
1989 59
1990 71
1991 75
1992 78
1993 91
1994 87
1995 84
1996 83
1997 70
1998 95
1999 116
2000 123
2001 112
2002 145
2003 146
2004 184
2005 216
2006 226
2007 223
2008 239
2009 221
2010 288
2011 300
2012 345
2013 349
2014 337
2015 369
2016 378
2017 354
2018 399
2019 398
2020 498
2021 477
2022 654
2023 582
2024 265

Search Results

8,700 results

Results by year

Filters applied: . Clear all
Page 1
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Strickler JH, Cercek A, Siena S, André T, Ng K, Van Cutsem E, Wu C, Paulson AS, Hubbard JM, Coveler AL, Fountzilas C, Kardosh A, Kasi PM, Lenz HJ, Ciombor KK, Elez E, Bajor DL, Cremolini C, Sanchez F, Stecher M, Feng W, Bekaii-Saab TS; MOUNTAINEER investigators. Strickler JH, et al. Lancet Oncol. 2023 May;24(5):496-508. doi: 10.1016/S1470-2045(23)00150-X. Lancet Oncol. 2023. PMID: 37142372 Clinical Trial.
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update.
Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA. Baxter NN, et al. J Clin Oncol. 2022 Mar 10;40(8):892-910. doi: 10.1200/JCO.21.02538. Epub 2021 Dec 22. J Clin Oncol. 2022. PMID: 34936379
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S. Sargent DJ, et al. J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498393 Free PMC article.
Celecoxib for Stage III Colon Cancer.
Kerr DJ, Chamberlain S, Kerr RS. Kerr DJ, et al. JAMA. 2021 Apr 6;325(13):1257-1258. doi: 10.1001/jama.2021.2651. JAMA. 2021. PMID: 33821916 No abstract available.
Systemic Therapy for Colon Cancer.
Wu C. Wu C. Surg Oncol Clin N Am. 2018 Apr;27(2):235-242. doi: 10.1016/j.soc.2017.11.001. Epub 2017 Dec 16. Surg Oncol Clin N Am. 2018. PMID: 29496087 Review.
Informed Bayesian survival analysis.
Bartoš F, Aust F, Haaf JM. Bartoš F, et al. BMC Med Res Methodol. 2022 Sep 10;22(1):238. doi: 10.1186/s12874-022-01676-9. BMC Med Res Methodol. 2022. PMID: 36088281 Free PMC article.
8,700 results